USC.edu
Are You a Patient?

Deepa Bhojwani, MBBS, DCH

Professor of Pediatrics (Clinical Scholar)

Image of Deepa Bhojwani, MBBS, DCH
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Publications

  • Integrin Alpha 4 Inhibition Prolongs the Survival of NSG Mice Engrafted with CD19-Negative Post-CART19 Relapsed B-ALL. Exp Hematol. 2026 Sep; 161:105471.. View in PubMed
  • Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia. Leukemia. 2026 Jul; 40(7):1542-1546.. View in PubMed
  • CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review. Blood Adv. 2026 May 26; 10(10):3467-3479.. View in PubMed
  • Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium report. Blood Neoplasia. 2026 Aug; 3(3):100247.. View in PubMed
  • Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia. Leukemia. 2026 Aug; 40(8):1797-1801.. View in PubMed
  • The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2026 Apr; 23(4):260-278.. View in PubMed
  • Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report. Blood Adv. 2025 Nov 25; 9(22):5738-5751.. View in PubMed
  • Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes. Mod Pathol. 2026 Jan; 39(1):100937.. View in PubMed
  • Biophysically constrained dynamical modelling of the brain using multimodal magnetic resonance imaging. Brain Res Bull. 2025 Oct 15; 231:111541.. View in PubMed
  • Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies. Blood. 2025 Sep 04; 146(10):1163-1173.. View in PubMed

Similar People